ArticleFrontiers in oncology2022

CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer.

Michael Wessolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.